Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Blocking the mineralocorticoid receptor improves wound healing by reducing inflammation and promoting blood vessel growth.

Compound 7p shows strong potential as an anticancer agent.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Finding functions for unknown GPCRs is hard but key for making new drugs.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Ritlecitinib was generally well tolerated in children with alopecia areata.

New drug uses show promise but need more research.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

Rat hair follicle stem cells have functional oxytocin receptors, useful for studying neuropsychiatric disorders.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Early sunburn treatment with certain inhibitors may reduce skin cancer risk.

Some drugs linked to growth hormones may increase the chance of hair loss in women.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Researchers made new compounds that could potentially be developed into anticancer drugs.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

Compounds from turmeric and bitter show strong potential as antiviral agents against the influenza A virus.

RU 58841 may treat acne, hair loss, and excessive hair growth.

Brassinosteroids may be useful in treating cancer, infections, and other diseases.

KATP channel openers may cause peripheral edema by reducing lymphatic contractions and flow.

Compounds from Eclipta prostrata L. plant have diabetes and obesity-fighting properties and reduce inflammation.

The diphosphonate was the most effective at preventing calcification in rats.

Chlormadinone acetate is useful for birth control and treating various hormonal issues.

Analog 23 is a promising compound for prostate cancer treatment.